nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilostazol—PDE3A—Anagrelide—hematologic cancer	0.204	0.29	CbGbCtD
Cilostazol—CYP1A2—Anagrelide—hematologic cancer	0.0229	0.0327	CbGbCtD
Cilostazol—CYP3A7—Ifosfamide—hematologic cancer	0.0134	0.0191	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.0134	0.0191	CbGbCtD
Cilostazol—CYP3A7—Imatinib—hematologic cancer	0.0128	0.0182	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.0128	0.0182	CbGbCtD
Cilostazol—CYP3A5—Daunorubicin—hematologic cancer	0.0125	0.0178	CbGbCtD
Cilostazol—CYP2D6—Lomustine—hematologic cancer	0.0122	0.0173	CbGbCtD
Cilostazol—CYP1A2—Carmustine—hematologic cancer	0.012	0.0172	CbGbCtD
Cilostazol—CYP3A5—Thalidomide—hematologic cancer	0.0114	0.0162	CbGbCtD
Cilostazol—CYP3A5—Teniposide—hematologic cancer	0.0109	0.0155	CbGbCtD
Cilostazol—CYP2D6—Idarubicin—hematologic cancer	0.0109	0.0155	CbGbCtD
Cilostazol—CYP2C19—Bortezomib—hematologic cancer	0.0106	0.015	CbGbCtD
Cilostazol—CYP1A2—Methoxsalen—hematologic cancer	0.0102	0.0146	CbGbCtD
Cilostazol—CYP3A5—Ifosfamide—hematologic cancer	0.01	0.0143	CbGbCtD
Cilostazol—CYP1A2—Bortezomib—hematologic cancer	0.00974	0.0139	CbGbCtD
Cilostazol—CYP3A5—Imatinib—hematologic cancer	0.00959	0.0137	CbGbCtD
Cilostazol—CYP1A2—Daunorubicin—hematologic cancer	0.00932	0.0133	CbGbCtD
Cilostazol—CYP2D6—Hydroxyurea—hematologic cancer	0.00923	0.0131	CbGbCtD
Cilostazol—CYP2C19—Thalidomide—hematologic cancer	0.0092	0.0131	CbGbCtD
Cilostazol—CYP1A2—Alitretinoin—hematologic cancer	0.00913	0.013	CbGbCtD
Cilostazol—CYP2C19—Teniposide—hematologic cancer	0.00877	0.0125	CbGbCtD
Cilostazol—CYP1A2—Thalidomide—hematologic cancer	0.00849	0.0121	CbGbCtD
Cilostazol—CYP3A4—Bexarotene—hematologic cancer	0.00833	0.0119	CbGbCtD
Cilostazol—CYP2C19—Ifosfamide—hematologic cancer	0.0081	0.0115	CbGbCtD
Cilostazol—CYP2D6—Bortezomib—hematologic cancer	0.00803	0.0114	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00798	0.0114	CbGbCtD
Cilostazol—CYP3A7—Irinotecan—hematologic cancer	0.00798	0.0114	CbGbCtD
Cilostazol—CYP3A4—Busulfan—hematologic cancer	0.00774	0.011	CbGbCtD
Cilostazol—CYP3A4—Lomustine—hematologic cancer	0.00774	0.011	CbGbCtD
Cilostazol—CYP2C19—Imatinib—hematologic cancer	0.00773	0.011	CbGbCtD
Cilostazol—CYP3A5—Dasatinib—hematologic cancer	0.0077	0.011	CbGbCtD
Cilostazol—CYP1A2—Dacarbazine—hematologic cancer	0.0073	0.0104	CbGbCtD
Cilostazol—CYP1A2—Imatinib—hematologic cancer	0.00714	0.0102	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00698	0.00995	CbGbCtD
Cilostazol—CYP3A7—Vincristine—hematologic cancer	0.00698	0.00995	CbGbCtD
Cilostazol—CYP3A4—Thiotepa—hematologic cancer	0.0069	0.00983	CbGbCtD
Cilostazol—CYP3A5—Irinotecan—hematologic cancer	0.00599	0.00854	CbGbCtD
Cilostazol—CYP2D6—Imatinib—hematologic cancer	0.00588	0.00838	CbGbCtD
Cilostazol—CYP1A2—Dasatinib—hematologic cancer	0.00573	0.00817	CbGbCtD
Cilostazol—CYP3A4—Methoxsalen—hematologic cancer	0.00537	0.00765	CbGbCtD
Cilostazol—CYP2D6—Nilotinib—hematologic cancer	0.00534	0.00762	CbGbCtD
Cilostazol—CYP2D6—Vinorelbine—hematologic cancer	0.0053	0.00755	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00526	0.00749	CbGbCtD
Cilostazol—CYP3A7—Dexamethasone—hematologic cancer	0.00526	0.00749	CbGbCtD
Cilostazol—CYP3A5—Vincristine—hematologic cancer	0.00524	0.00746	CbGbCtD
Cilostazol—CYP3A4—Bortezomib—hematologic cancer	0.0051	0.00727	CbGbCtD
Cilostazol—CYP2C19—Prednisone—hematologic cancer	0.0051	0.00726	CbGbCtD
Cilostazol—CYP3A4—Daunorubicin—hematologic cancer	0.00488	0.00696	CbGbCtD
Cilostazol—CYP3A5—Etoposide—hematologic cancer	0.0048	0.00684	CbGbCtD
Cilostazol—CYP3A4—Cytarabine—hematologic cancer	0.00431	0.00614	CbGbCtD
Cilostazol—CYP3A4—Teniposide—hematologic cancer	0.00424	0.00604	CbGbCtD
Cilostazol—CYP3A5—Dexamethasone—hematologic cancer	0.00394	0.00562	CbGbCtD
Cilostazol—CYP3A4—Ifosfamide—hematologic cancer	0.00391	0.00558	CbGbCtD
Cilostazol—CYP3A4—Imatinib—hematologic cancer	0.00374	0.00533	CbGbCtD
Cilostazol—CYP1A2—Etoposide—hematologic cancer	0.00357	0.00509	CbGbCtD
Cilostazol—CYP3A4—Ruxolitinib—hematologic cancer	0.00352	0.00502	CbGbCtD
Cilostazol—CYP3A4—Nilotinib—hematologic cancer	0.0034	0.00484	CbGbCtD
Cilostazol—CYP3A4—Vinorelbine—hematologic cancer	0.00337	0.0048	CbGbCtD
Cilostazol—CYP2D6—Vinblastine—hematologic cancer	0.00327	0.00465	CbGbCtD
Cilostazol—CYP2C19—Dexamethasone—hematologic cancer	0.00318	0.00453	CbGbCtD
Cilostazol—CYP3A4—Triamcinolone—hematologic cancer	0.00308	0.00439	CbGbCtD
Cilostazol—CYP3A4—Dasatinib—hematologic cancer	0.003	0.00428	CbGbCtD
Cilostazol—CYP3A4—Mitoxantrone—hematologic cancer	0.00297	0.00423	CbGbCtD
Cilostazol—CYP3A4—Betamethasone—hematologic cancer	0.00264	0.00377	CbGbCtD
Cilostazol—CYP3A4—Prednisolone—hematologic cancer	0.00261	0.00372	CbGbCtD
Cilostazol—CYP3A4—Prednisone—hematologic cancer	0.00246	0.00351	CbGbCtD
Cilostazol—CYP2D6—Dexamethasone—hematologic cancer	0.00242	0.00345	CbGbCtD
Cilostazol—CYP3A4—Irinotecan—hematologic cancer	0.00234	0.00333	CbGbCtD
Cilostazol—Aripiprazole—H1F0—hematologic cancer	0.00213	0.906	CrCbGaD
Cilostazol—CYP3A4—Vinblastine—hematologic cancer	0.00208	0.00296	CbGbCtD
Cilostazol—CYP3A4—Vincristine—hematologic cancer	0.00204	0.00291	CbGbCtD
Cilostazol—CYP2D6—Doxorubicin—hematologic cancer	0.00201	0.00286	CbGbCtD
Cilostazol—CYP3A4—Etoposide—hematologic cancer	0.00187	0.00267	CbGbCtD
Cilostazol—CYP3A4—Dexamethasone—hematologic cancer	0.00154	0.00219	CbGbCtD
Cilostazol—CYP3A4—Doxorubicin—hematologic cancer	0.00128	0.00182	CbGbCtD
Cilostazol—Aripiprazole—ABCB1—hematologic cancer	0.00022	0.0937	CrCbGaD
Cilostazol—PDE3A—hematopoietic system—hematologic cancer	8.66e-05	0.138	CbGeAlD
Cilostazol—PDE3A—blood—hematologic cancer	5.74e-05	0.0911	CbGeAlD
Cilostazol—PDE3A—lung—hematologic cancer	5.03e-05	0.0799	CbGeAlD
Cilostazol—PDE3A—testis—hematologic cancer	4.75e-05	0.0754	CbGeAlD
Cilostazol—CYP2C19—hematopoietic system—hematologic cancer	4.69e-05	0.0746	CbGeAlD
Cilostazol—CYP1A2—hematopoietic system—hematologic cancer	3.83e-05	0.0609	CbGeAlD
Cilostazol—CYP3A5—hematopoietic system—hematologic cancer	3.7e-05	0.0587	CbGeAlD
Cilostazol—PDE3A—lymph node—hematologic cancer	3.44e-05	0.0546	CbGeAlD
Cilostazol—CYP2C19—blood—hematologic cancer	3.11e-05	0.0494	CbGeAlD
Cilostazol—CYP3A4—hematopoietic system—hematologic cancer	2.78e-05	0.0441	CbGeAlD
Cilostazol—CYP2D6—hematopoietic system—hematologic cancer	2.73e-05	0.0434	CbGeAlD
Cilostazol—CYP1A2—blood—hematologic cancer	2.54e-05	0.0403	CbGeAlD
Cilostazol—CYP3A5—blood—hematologic cancer	2.45e-05	0.0389	CbGeAlD
Cilostazol—Headache—Gemcitabine—hematologic cancer	2.3e-05	8.62e-05	CcSEcCtD
Cilostazol—Nausea—Vincristine—hematologic cancer	2.3e-05	8.61e-05	CcSEcCtD
Cilostazol—Cardiac disorder—Epirubicin—hematologic cancer	2.3e-05	8.6e-05	CcSEcCtD
Cilostazol—Rhinitis—Doxorubicin—hematologic cancer	2.3e-05	8.6e-05	CcSEcCtD
Cilostazol—Haemorrhage—Doxorubicin—hematologic cancer	2.29e-05	8.57e-05	CcSEcCtD
Cilostazol—Hypoaesthesia—Doxorubicin—hematologic cancer	2.28e-05	8.53e-05	CcSEcCtD
Cilostazol—Pharyngitis—Doxorubicin—hematologic cancer	2.28e-05	8.51e-05	CcSEcCtD
Cilostazol—Dyspepsia—Betamethasone—hematologic cancer	2.28e-05	8.51e-05	CcSEcCtD
Cilostazol—Dyspepsia—Dexamethasone—hematologic cancer	2.28e-05	8.51e-05	CcSEcCtD
Cilostazol—Urticaria—Triamcinolone—hematologic cancer	2.26e-05	8.46e-05	CcSEcCtD
Cilostazol—Oedema peripheral—Doxorubicin—hematologic cancer	2.26e-05	8.45e-05	CcSEcCtD
Cilostazol—Asthenia—Etoposide—hematologic cancer	2.25e-05	8.43e-05	CcSEcCtD
Cilostazol—Body temperature increased—Triamcinolone—hematologic cancer	2.25e-05	8.42e-05	CcSEcCtD
Cilostazol—Oedema—Prednisone—hematologic cancer	2.25e-05	8.42e-05	CcSEcCtD
Cilostazol—Angiopathy—Epirubicin—hematologic cancer	2.25e-05	8.41e-05	CcSEcCtD
Cilostazol—Decreased appetite—Betamethasone—hematologic cancer	2.25e-05	8.4e-05	CcSEcCtD
Cilostazol—Decreased appetite—Dexamethasone—hematologic cancer	2.25e-05	8.4e-05	CcSEcCtD
Cilostazol—Nausea—Irinotecan—hematologic cancer	2.24e-05	8.39e-05	CcSEcCtD
Cilostazol—Nausea—Mitoxantrone—hematologic cancer	2.24e-05	8.39e-05	CcSEcCtD
Cilostazol—Infection—Prednisone—hematologic cancer	2.24e-05	8.36e-05	CcSEcCtD
Cilostazol—Mediastinal disorder—Epirubicin—hematologic cancer	2.23e-05	8.35e-05	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Dexamethasone—hematologic cancer	2.23e-05	8.34e-05	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.23e-05	8.34e-05	CcSEcCtD
Cilostazol—Back pain—Methotrexate—hematologic cancer	2.23e-05	8.34e-05	CcSEcCtD
Cilostazol—CYP1A2—lung—hematologic cancer	2.23e-05	0.0354	CbGeAlD
Cilostazol—Chills—Epirubicin—hematologic cancer	2.22e-05	8.31e-05	CcSEcCtD
Cilostazol—Pruritus—Etoposide—hematologic cancer	2.22e-05	8.31e-05	CcSEcCtD
Cilostazol—Shock—Prednisone—hematologic cancer	2.21e-05	8.28e-05	CcSEcCtD
Cilostazol—Pain—Dexamethasone—hematologic cancer	2.21e-05	8.27e-05	CcSEcCtD
Cilostazol—Pain—Betamethasone—hematologic cancer	2.21e-05	8.27e-05	CcSEcCtD
Cilostazol—Nervous system disorder—Prednisone—hematologic cancer	2.21e-05	8.25e-05	CcSEcCtD
Cilostazol—Tachycardia—Prednisone—hematologic cancer	2.2e-05	8.22e-05	CcSEcCtD
Cilostazol—Skin disorder—Prednisone—hematologic cancer	2.19e-05	8.18e-05	CcSEcCtD
Cilostazol—Nausea—Gemcitabine—hematologic cancer	2.18e-05	8.17e-05	CcSEcCtD
Cilostazol—Vomiting—Cisplatin—hematologic cancer	2.18e-05	8.15e-05	CcSEcCtD
Cilostazol—Erythema multiforme—Doxorubicin—hematologic cancer	2.17e-05	8.11e-05	CcSEcCtD
Cilostazol—Rash—Cisplatin—hematologic cancer	2.16e-05	8.08e-05	CcSEcCtD
Cilostazol—Dermatitis—Cisplatin—hematologic cancer	2.16e-05	8.08e-05	CcSEcCtD
Cilostazol—Diarrhoea—Etoposide—hematologic cancer	2.15e-05	8.04e-05	CcSEcCtD
Cilostazol—CYP3A5—lung—hematologic cancer	2.15e-05	0.0341	CbGeAlD
Cilostazol—Anorexia—Prednisone—hematologic cancer	2.15e-05	8.02e-05	CcSEcCtD
Cilostazol—Ill-defined disorder—Methotrexate—hematologic cancer	2.14e-05	8e-05	CcSEcCtD
Cilostazol—Tinnitus—Doxorubicin—hematologic cancer	2.14e-05	7.99e-05	CcSEcCtD
Cilostazol—Anaemia—Methotrexate—hematologic cancer	2.13e-05	7.97e-05	CcSEcCtD
Cilostazol—Feeling abnormal—Dexamethasone—hematologic cancer	2.13e-05	7.97e-05	CcSEcCtD
Cilostazol—Feeling abnormal—Betamethasone—hematologic cancer	2.13e-05	7.97e-05	CcSEcCtD
Cilostazol—Cardiac disorder—Doxorubicin—hematologic cancer	2.13e-05	7.96e-05	CcSEcCtD
Cilostazol—Flatulence—Epirubicin—hematologic cancer	2.13e-05	7.95e-05	CcSEcCtD
Cilostazol—Gastrointestinal pain—Betamethasone—hematologic cancer	2.11e-05	7.9e-05	CcSEcCtD
Cilostazol—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.11e-05	7.9e-05	CcSEcCtD
Cilostazol—Back pain—Epirubicin—hematologic cancer	2.09e-05	7.8e-05	CcSEcCtD
Cilostazol—Angiopathy—Doxorubicin—hematologic cancer	2.08e-05	7.78e-05	CcSEcCtD
Cilostazol—Malaise—Methotrexate—hematologic cancer	2.08e-05	7.77e-05	CcSEcCtD
Cilostazol—Dizziness—Etoposide—hematologic cancer	2.08e-05	7.77e-05	CcSEcCtD
Cilostazol—Muscle spasms—Epirubicin—hematologic cancer	2.07e-05	7.76e-05	CcSEcCtD
Cilostazol—Vertigo—Methotrexate—hematologic cancer	2.07e-05	7.74e-05	CcSEcCtD
Cilostazol—Mediastinal disorder—Doxorubicin—hematologic cancer	2.07e-05	7.73e-05	CcSEcCtD
Cilostazol—Leukopenia—Methotrexate—hematologic cancer	2.06e-05	7.72e-05	CcSEcCtD
Cilostazol—Chills—Doxorubicin—hematologic cancer	2.06e-05	7.69e-05	CcSEcCtD
Cilostazol—Urticaria—Dexamethasone—hematologic cancer	2.05e-05	7.68e-05	CcSEcCtD
Cilostazol—Urticaria—Betamethasone—hematologic cancer	2.05e-05	7.68e-05	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.05e-05	7.67e-05	CcSEcCtD
Cilostazol—Dizziness—Prednisolone—hematologic cancer	2.05e-05	7.66e-05	CcSEcCtD
Cilostazol—Asthenia—Triamcinolone—hematologic cancer	2.04e-05	7.64e-05	CcSEcCtD
Cilostazol—Body temperature increased—Dexamethasone—hematologic cancer	2.04e-05	7.64e-05	CcSEcCtD
Cilostazol—Body temperature increased—Betamethasone—hematologic cancer	2.04e-05	7.64e-05	CcSEcCtD
Cilostazol—Abdominal pain—Betamethasone—hematologic cancer	2.04e-05	7.64e-05	CcSEcCtD
Cilostazol—Abdominal pain—Dexamethasone—hematologic cancer	2.04e-05	7.64e-05	CcSEcCtD
Cilostazol—Nausea—Cisplatin—hematologic cancer	2.04e-05	7.61e-05	CcSEcCtD
Cilostazol—Insomnia—Prednisone—hematologic cancer	2.04e-05	7.61e-05	CcSEcCtD
Cilostazol—Paraesthesia—Prednisone—hematologic cancer	2.02e-05	7.56e-05	CcSEcCtD
Cilostazol—Pruritus—Triamcinolone—hematologic cancer	2.02e-05	7.54e-05	CcSEcCtD
Cilostazol—Cough—Methotrexate—hematologic cancer	2.01e-05	7.52e-05	CcSEcCtD
Cilostazol—Ill-defined disorder—Epirubicin—hematologic cancer	2e-05	7.48e-05	CcSEcCtD
Cilostazol—Vomiting—Etoposide—hematologic cancer	2e-05	7.47e-05	CcSEcCtD
Cilostazol—Anaemia—Epirubicin—hematologic cancer	1.99e-05	7.46e-05	CcSEcCtD
Cilostazol—Dyspepsia—Prednisone—hematologic cancer	1.98e-05	7.41e-05	CcSEcCtD
Cilostazol—Rash—Etoposide—hematologic cancer	1.98e-05	7.41e-05	CcSEcCtD
Cilostazol—Dermatitis—Etoposide—hematologic cancer	1.98e-05	7.4e-05	CcSEcCtD
Cilostazol—Headache—Etoposide—hematologic cancer	1.97e-05	7.36e-05	CcSEcCtD
Cilostazol—Flatulence—Doxorubicin—hematologic cancer	1.97e-05	7.35e-05	CcSEcCtD
Cilostazol—Myalgia—Methotrexate—hematologic cancer	1.96e-05	7.34e-05	CcSEcCtD
Cilostazol—Arthralgia—Methotrexate—hematologic cancer	1.96e-05	7.34e-05	CcSEcCtD
Cilostazol—Chest pain—Methotrexate—hematologic cancer	1.96e-05	7.34e-05	CcSEcCtD
Cilostazol—Decreased appetite—Prednisone—hematologic cancer	1.96e-05	7.32e-05	CcSEcCtD
Cilostazol—Rash—Prednisolone—hematologic cancer	1.95e-05	7.3e-05	CcSEcCtD
Cilostazol—Dermatitis—Prednisolone—hematologic cancer	1.95e-05	7.3e-05	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.95e-05	7.29e-05	CcSEcCtD
Cilostazol—Malaise—Epirubicin—hematologic cancer	1.95e-05	7.27e-05	CcSEcCtD
Cilostazol—Headache—Prednisolone—hematologic cancer	1.94e-05	7.26e-05	CcSEcCtD
Cilostazol—Discomfort—Methotrexate—hematologic cancer	1.94e-05	7.25e-05	CcSEcCtD
Cilostazol—Vertigo—Epirubicin—hematologic cancer	1.94e-05	7.25e-05	CcSEcCtD
Cilostazol—Syncope—Epirubicin—hematologic cancer	1.93e-05	7.23e-05	CcSEcCtD
Cilostazol—Leukopenia—Epirubicin—hematologic cancer	1.93e-05	7.22e-05	CcSEcCtD
Cilostazol—Back pain—Doxorubicin—hematologic cancer	1.93e-05	7.22e-05	CcSEcCtD
Cilostazol—Muscle spasms—Doxorubicin—hematologic cancer	1.92e-05	7.18e-05	CcSEcCtD
Cilostazol—Palpitations—Epirubicin—hematologic cancer	1.91e-05	7.13e-05	CcSEcCtD
Cilostazol—Loss of consciousness—Epirubicin—hematologic cancer	1.9e-05	7.09e-05	CcSEcCtD
Cilostazol—Dizziness—Triamcinolone—hematologic cancer	1.88e-05	7.04e-05	CcSEcCtD
Cilostazol—Cough—Epirubicin—hematologic cancer	1.88e-05	7.04e-05	CcSEcCtD
Cilostazol—Infection—Methotrexate—hematologic cancer	1.87e-05	6.99e-05	CcSEcCtD
Cilostazol—Nausea—Etoposide—hematologic cancer	1.87e-05	6.98e-05	CcSEcCtD
Cilostazol—Hypertension—Epirubicin—hematologic cancer	1.86e-05	6.96e-05	CcSEcCtD
Cilostazol—Feeling abnormal—Prednisone—hematologic cancer	1.85e-05	6.94e-05	CcSEcCtD
Cilostazol—Asthenia—Dexamethasone—hematologic cancer	1.85e-05	6.93e-05	CcSEcCtD
Cilostazol—Asthenia—Betamethasone—hematologic cancer	1.85e-05	6.93e-05	CcSEcCtD
Cilostazol—Ill-defined disorder—Doxorubicin—hematologic cancer	1.85e-05	6.93e-05	CcSEcCtD
Cilostazol—Nervous system disorder—Methotrexate—hematologic cancer	1.84e-05	6.9e-05	CcSEcCtD
Cilostazol—Anaemia—Doxorubicin—hematologic cancer	1.84e-05	6.9e-05	CcSEcCtD
Cilostazol—Thrombocytopenia—Methotrexate—hematologic cancer	1.84e-05	6.89e-05	CcSEcCtD
Cilostazol—Gastrointestinal pain—Prednisone—hematologic cancer	1.84e-05	6.88e-05	CcSEcCtD
Cilostazol—Nausea—Prednisolone—hematologic cancer	1.84e-05	6.88e-05	CcSEcCtD
Cilostazol—CYP3A4—blood—hematologic cancer	1.84e-05	0.0292	CbGeAlD
Cilostazol—Arthralgia—Epirubicin—hematologic cancer	1.84e-05	6.87e-05	CcSEcCtD
Cilostazol—Myalgia—Epirubicin—hematologic cancer	1.84e-05	6.87e-05	CcSEcCtD
Cilostazol—Chest pain—Epirubicin—hematologic cancer	1.84e-05	6.87e-05	CcSEcCtD
Cilostazol—Anxiety—Epirubicin—hematologic cancer	1.83e-05	6.84e-05	CcSEcCtD
Cilostazol—Pruritus—Dexamethasone—hematologic cancer	1.83e-05	6.84e-05	CcSEcCtD
Cilostazol—Pruritus—Betamethasone—hematologic cancer	1.83e-05	6.84e-05	CcSEcCtD
Cilostazol—Skin disorder—Methotrexate—hematologic cancer	1.83e-05	6.83e-05	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.82e-05	6.82e-05	CcSEcCtD
Cilostazol—Discomfort—Epirubicin—hematologic cancer	1.81e-05	6.79e-05	CcSEcCtD
Cilostazol—Vomiting—Triamcinolone—hematologic cancer	1.81e-05	6.77e-05	CcSEcCtD
Cilostazol—CYP2D6—blood—hematologic cancer	1.81e-05	0.0287	CbGeAlD
Cilostazol—Malaise—Doxorubicin—hematologic cancer	1.8e-05	6.73e-05	CcSEcCtD
Cilostazol—Rash—Triamcinolone—hematologic cancer	1.8e-05	6.72e-05	CcSEcCtD
Cilostazol—Dermatitis—Triamcinolone—hematologic cancer	1.79e-05	6.71e-05	CcSEcCtD
Cilostazol—Vertigo—Doxorubicin—hematologic cancer	1.79e-05	6.71e-05	CcSEcCtD
Cilostazol—Anorexia—Methotrexate—hematologic cancer	1.79e-05	6.71e-05	CcSEcCtD
Cilostazol—Syncope—Doxorubicin—hematologic cancer	1.79e-05	6.69e-05	CcSEcCtD
Cilostazol—Urticaria—Prednisone—hematologic cancer	1.79e-05	6.69e-05	CcSEcCtD
Cilostazol—Leukopenia—Doxorubicin—hematologic cancer	1.79e-05	6.68e-05	CcSEcCtD
Cilostazol—Headache—Triamcinolone—hematologic cancer	1.78e-05	6.67e-05	CcSEcCtD
Cilostazol—Body temperature increased—Prednisone—hematologic cancer	1.78e-05	6.65e-05	CcSEcCtD
Cilostazol—Abdominal pain—Prednisone—hematologic cancer	1.78e-05	6.65e-05	CcSEcCtD
Cilostazol—Diarrhoea—Dexamethasone—hematologic cancer	1.77e-05	6.61e-05	CcSEcCtD
Cilostazol—Diarrhoea—Betamethasone—hematologic cancer	1.77e-05	6.61e-05	CcSEcCtD
Cilostazol—Palpitations—Doxorubicin—hematologic cancer	1.76e-05	6.6e-05	CcSEcCtD
Cilostazol—Oedema—Epirubicin—hematologic cancer	1.76e-05	6.58e-05	CcSEcCtD
Cilostazol—Hypotension—Methotrexate—hematologic cancer	1.76e-05	6.57e-05	CcSEcCtD
Cilostazol—Loss of consciousness—Doxorubicin—hematologic cancer	1.75e-05	6.56e-05	CcSEcCtD
Cilostazol—Infection—Epirubicin—hematologic cancer	1.75e-05	6.54e-05	CcSEcCtD
Cilostazol—Cough—Doxorubicin—hematologic cancer	1.74e-05	6.51e-05	CcSEcCtD
Cilostazol—Shock—Epirubicin—hematologic cancer	1.73e-05	6.48e-05	CcSEcCtD
Cilostazol—Nervous system disorder—Epirubicin—hematologic cancer	1.73e-05	6.46e-05	CcSEcCtD
Cilostazol—Thrombocytopenia—Epirubicin—hematologic cancer	1.72e-05	6.45e-05	CcSEcCtD
Cilostazol—Hypertension—Doxorubicin—hematologic cancer	1.72e-05	6.44e-05	CcSEcCtD
Cilostazol—Tachycardia—Epirubicin—hematologic cancer	1.72e-05	6.43e-05	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.71e-05	6.41e-05	CcSEcCtD
Cilostazol—Skin disorder—Epirubicin—hematologic cancer	1.71e-05	6.39e-05	CcSEcCtD
Cilostazol—Dizziness—Betamethasone—hematologic cancer	1.71e-05	6.39e-05	CcSEcCtD
Cilostazol—Dizziness—Dexamethasone—hematologic cancer	1.71e-05	6.39e-05	CcSEcCtD
Cilostazol—Insomnia—Methotrexate—hematologic cancer	1.7e-05	6.36e-05	CcSEcCtD
Cilostazol—Arthralgia—Doxorubicin—hematologic cancer	1.7e-05	6.35e-05	CcSEcCtD
Cilostazol—Myalgia—Doxorubicin—hematologic cancer	1.7e-05	6.35e-05	CcSEcCtD
Cilostazol—Chest pain—Doxorubicin—hematologic cancer	1.7e-05	6.35e-05	CcSEcCtD
Cilostazol—Anxiety—Doxorubicin—hematologic cancer	1.69e-05	6.33e-05	CcSEcCtD
Cilostazol—Nausea—Triamcinolone—hematologic cancer	1.69e-05	6.33e-05	CcSEcCtD
Cilostazol—Paraesthesia—Methotrexate—hematologic cancer	1.69e-05	6.32e-05	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.69e-05	6.31e-05	CcSEcCtD
Cilostazol—Discomfort—Doxorubicin—hematologic cancer	1.68e-05	6.28e-05	CcSEcCtD
Cilostazol—Anorexia—Epirubicin—hematologic cancer	1.68e-05	6.28e-05	CcSEcCtD
Cilostazol—Dyspnoea—Methotrexate—hematologic cancer	1.68e-05	6.27e-05	CcSEcCtD
Cilostazol—Dyspepsia—Methotrexate—hematologic cancer	1.66e-05	6.19e-05	CcSEcCtD
Cilostazol—Hypotension—Epirubicin—hematologic cancer	1.64e-05	6.15e-05	CcSEcCtD
Cilostazol—Vomiting—Dexamethasone—hematologic cancer	1.64e-05	6.15e-05	CcSEcCtD
Cilostazol—Vomiting—Betamethasone—hematologic cancer	1.64e-05	6.15e-05	CcSEcCtD
Cilostazol—Decreased appetite—Methotrexate—hematologic cancer	1.64e-05	6.12e-05	CcSEcCtD
Cilostazol—Rash—Dexamethasone—hematologic cancer	1.63e-05	6.09e-05	CcSEcCtD
Cilostazol—Rash—Betamethasone—hematologic cancer	1.63e-05	6.09e-05	CcSEcCtD
Cilostazol—Oedema—Doxorubicin—hematologic cancer	1.63e-05	6.09e-05	CcSEcCtD
Cilostazol—Dermatitis—Betamethasone—hematologic cancer	1.63e-05	6.09e-05	CcSEcCtD
Cilostazol—Dermatitis—Dexamethasone—hematologic cancer	1.63e-05	6.09e-05	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.62e-05	6.07e-05	CcSEcCtD
Cilostazol—Headache—Betamethasone—hematologic cancer	1.62e-05	6.06e-05	CcSEcCtD
Cilostazol—Headache—Dexamethasone—hematologic cancer	1.62e-05	6.06e-05	CcSEcCtD
Cilostazol—Infection—Doxorubicin—hematologic cancer	1.62e-05	6.05e-05	CcSEcCtD
Cilostazol—Asthenia—Prednisone—hematologic cancer	1.61e-05	6.04e-05	CcSEcCtD
Cilostazol—Pain—Methotrexate—hematologic cancer	1.61e-05	6.02e-05	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.6e-05	6e-05	CcSEcCtD
Cilostazol—Shock—Doxorubicin—hematologic cancer	1.6e-05	5.99e-05	CcSEcCtD
Cilostazol—Nervous system disorder—Doxorubicin—hematologic cancer	1.6e-05	5.97e-05	CcSEcCtD
Cilostazol—Thrombocytopenia—Doxorubicin—hematologic cancer	1.59e-05	5.96e-05	CcSEcCtD
Cilostazol—Pruritus—Prednisone—hematologic cancer	1.59e-05	5.96e-05	CcSEcCtD
Cilostazol—Insomnia—Epirubicin—hematologic cancer	1.59e-05	5.95e-05	CcSEcCtD
Cilostazol—Tachycardia—Doxorubicin—hematologic cancer	1.59e-05	5.95e-05	CcSEcCtD
Cilostazol—Skin disorder—Doxorubicin—hematologic cancer	1.58e-05	5.92e-05	CcSEcCtD
Cilostazol—Paraesthesia—Epirubicin—hematologic cancer	1.58e-05	5.91e-05	CcSEcCtD
Cilostazol—Dyspnoea—Epirubicin—hematologic cancer	1.57e-05	5.87e-05	CcSEcCtD
Cilostazol—Anorexia—Doxorubicin—hematologic cancer	1.55e-05	5.81e-05	CcSEcCtD
Cilostazol—Feeling abnormal—Methotrexate—hematologic cancer	1.55e-05	5.8e-05	CcSEcCtD
Cilostazol—Dyspepsia—Epirubicin—hematologic cancer	1.55e-05	5.8e-05	CcSEcCtD
Cilostazol—Diarrhoea—Prednisone—hematologic cancer	1.54e-05	5.76e-05	CcSEcCtD
Cilostazol—Gastrointestinal pain—Methotrexate—hematologic cancer	1.54e-05	5.75e-05	CcSEcCtD
Cilostazol—Nausea—Dexamethasone—hematologic cancer	1.54e-05	5.74e-05	CcSEcCtD
Cilostazol—Nausea—Betamethasone—hematologic cancer	1.54e-05	5.74e-05	CcSEcCtD
Cilostazol—Decreased appetite—Epirubicin—hematologic cancer	1.53e-05	5.72e-05	CcSEcCtD
Cilostazol—Hypotension—Doxorubicin—hematologic cancer	1.52e-05	5.69e-05	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.52e-05	5.68e-05	CcSEcCtD
Cilostazol—Pain—Epirubicin—hematologic cancer	1.51e-05	5.63e-05	CcSEcCtD
Cilostazol—CYP2D6—testis—hematologic cancer	1.5e-05	0.0238	CbGeAlD
Cilostazol—Urticaria—Methotrexate—hematologic cancer	1.49e-05	5.59e-05	CcSEcCtD
Cilostazol—Dizziness—Prednisone—hematologic cancer	1.49e-05	5.57e-05	CcSEcCtD
Cilostazol—Abdominal pain—Methotrexate—hematologic cancer	1.49e-05	5.56e-05	CcSEcCtD
Cilostazol—Body temperature increased—Methotrexate—hematologic cancer	1.49e-05	5.56e-05	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.48e-05	5.55e-05	CcSEcCtD
Cilostazol—Insomnia—Doxorubicin—hematologic cancer	1.47e-05	5.51e-05	CcSEcCtD
Cilostazol—Paraesthesia—Doxorubicin—hematologic cancer	1.46e-05	5.47e-05	CcSEcCtD
Cilostazol—Dyspnoea—Doxorubicin—hematologic cancer	1.45e-05	5.43e-05	CcSEcCtD
Cilostazol—Feeling abnormal—Epirubicin—hematologic cancer	1.45e-05	5.43e-05	CcSEcCtD
Cilostazol—Gastrointestinal pain—Epirubicin—hematologic cancer	1.44e-05	5.38e-05	CcSEcCtD
Cilostazol—Dyspepsia—Doxorubicin—hematologic cancer	1.43e-05	5.36e-05	CcSEcCtD
Cilostazol—Vomiting—Prednisone—hematologic cancer	1.43e-05	5.35e-05	CcSEcCtD
Cilostazol—Rash—Prednisone—hematologic cancer	1.42e-05	5.31e-05	CcSEcCtD
Cilostazol—Dermatitis—Prednisone—hematologic cancer	1.42e-05	5.3e-05	CcSEcCtD
Cilostazol—Decreased appetite—Doxorubicin—hematologic cancer	1.42e-05	5.3e-05	CcSEcCtD
Cilostazol—Headache—Prednisone—hematologic cancer	1.41e-05	5.27e-05	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.41e-05	5.26e-05	CcSEcCtD
Cilostazol—Urticaria—Epirubicin—hematologic cancer	1.4e-05	5.23e-05	CcSEcCtD
Cilostazol—Pain—Doxorubicin—hematologic cancer	1.39e-05	5.21e-05	CcSEcCtD
Cilostazol—Body temperature increased—Epirubicin—hematologic cancer	1.39e-05	5.2e-05	CcSEcCtD
Cilostazol—Abdominal pain—Epirubicin—hematologic cancer	1.39e-05	5.2e-05	CcSEcCtD
Cilostazol—Asthenia—Methotrexate—hematologic cancer	1.35e-05	5.05e-05	CcSEcCtD
Cilostazol—Feeling abnormal—Doxorubicin—hematologic cancer	1.34e-05	5.02e-05	CcSEcCtD
Cilostazol—Nausea—Prednisone—hematologic cancer	1.34e-05	5e-05	CcSEcCtD
Cilostazol—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.33e-05	4.98e-05	CcSEcCtD
Cilostazol—Pruritus—Methotrexate—hematologic cancer	1.33e-05	4.98e-05	CcSEcCtD
Cilostazol—Urticaria—Doxorubicin—hematologic cancer	1.29e-05	4.84e-05	CcSEcCtD
Cilostazol—Body temperature increased—Doxorubicin—hematologic cancer	1.29e-05	4.82e-05	CcSEcCtD
Cilostazol—Abdominal pain—Doxorubicin—hematologic cancer	1.29e-05	4.82e-05	CcSEcCtD
Cilostazol—Diarrhoea—Methotrexate—hematologic cancer	1.29e-05	4.81e-05	CcSEcCtD
Cilostazol—Asthenia—Epirubicin—hematologic cancer	1.26e-05	4.72e-05	CcSEcCtD
Cilostazol—Pruritus—Epirubicin—hematologic cancer	1.25e-05	4.66e-05	CcSEcCtD
Cilostazol—Dizziness—Methotrexate—hematologic cancer	1.24e-05	4.65e-05	CcSEcCtD
Cilostazol—Diarrhoea—Epirubicin—hematologic cancer	1.2e-05	4.5e-05	CcSEcCtD
Cilostazol—Vomiting—Methotrexate—hematologic cancer	1.2e-05	4.47e-05	CcSEcCtD
Cilostazol—Rash—Methotrexate—hematologic cancer	1.19e-05	4.44e-05	CcSEcCtD
Cilostazol—Dermatitis—Methotrexate—hematologic cancer	1.18e-05	4.43e-05	CcSEcCtD
Cilostazol—Headache—Methotrexate—hematologic cancer	1.18e-05	4.41e-05	CcSEcCtD
Cilostazol—Asthenia—Doxorubicin—hematologic cancer	1.17e-05	4.37e-05	CcSEcCtD
Cilostazol—Dizziness—Epirubicin—hematologic cancer	1.16e-05	4.35e-05	CcSEcCtD
Cilostazol—Pruritus—Doxorubicin—hematologic cancer	1.15e-05	4.31e-05	CcSEcCtD
Cilostazol—Vomiting—Epirubicin—hematologic cancer	1.12e-05	4.19e-05	CcSEcCtD
Cilostazol—Nausea—Methotrexate—hematologic cancer	1.12e-05	4.18e-05	CcSEcCtD
Cilostazol—Diarrhoea—Doxorubicin—hematologic cancer	1.11e-05	4.17e-05	CcSEcCtD
Cilostazol—Rash—Epirubicin—hematologic cancer	1.11e-05	4.15e-05	CcSEcCtD
Cilostazol—Dermatitis—Epirubicin—hematologic cancer	1.11e-05	4.15e-05	CcSEcCtD
Cilostazol—Headache—Epirubicin—hematologic cancer	1.1e-05	4.12e-05	CcSEcCtD
Cilostazol—Dizziness—Doxorubicin—hematologic cancer	1.08e-05	4.03e-05	CcSEcCtD
Cilostazol—Nausea—Epirubicin—hematologic cancer	1.05e-05	3.91e-05	CcSEcCtD
Cilostazol—Vomiting—Doxorubicin—hematologic cancer	1.04e-05	3.87e-05	CcSEcCtD
Cilostazol—Rash—Doxorubicin—hematologic cancer	1.03e-05	3.84e-05	CcSEcCtD
Cilostazol—Dermatitis—Doxorubicin—hematologic cancer	1.03e-05	3.84e-05	CcSEcCtD
Cilostazol—Headache—Doxorubicin—hematologic cancer	1.02e-05	3.82e-05	CcSEcCtD
Cilostazol—Nausea—Doxorubicin—hematologic cancer	9.68e-06	3.62e-05	CcSEcCtD
Cilostazol—CYP2C19—Metabolism—SPHK1—hematologic cancer	6.13e-06	0.000219	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NCOR2—hematologic cancer	6.11e-06	0.000218	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—FGF2—hematologic cancer	6.1e-06	0.000218	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—AGRN—hematologic cancer	6.05e-06	0.000216	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PC—hematologic cancer	6.05e-06	0.000216	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GSTP1—hematologic cancer	6.02e-06	0.000215	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PIK3R1—hematologic cancer	6.02e-06	0.000215	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—UGT1A1—hematologic cancer	5.89e-06	0.00021	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—JAK2—hematologic cancer	5.85e-06	0.000209	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GBA—hematologic cancer	5.84e-06	0.000209	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SLC35B2—hematologic cancer	5.84e-06	0.000209	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—IDH1—hematologic cancer	5.82e-06	0.000208	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ABCC3—hematologic cancer	5.76e-06	0.000206	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—TXN—hematologic cancer	5.76e-06	0.000206	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTO1—hematologic cancer	5.76e-06	0.000206	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—IDH2—hematologic cancer	5.74e-06	0.000205	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—HMMR—hematologic cancer	5.74e-06	0.000205	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—PIK3CA—hematologic cancer	5.73e-06	0.000205	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—SLC22A1—hematologic cancer	5.73e-06	0.000205	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CRABP1—hematologic cancer	5.73e-06	0.000205	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MDM2—hematologic cancer	5.71e-06	0.000204	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ABCB1—hematologic cancer	5.7e-06	0.000204	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—SPHK1—hematologic cancer	5.63e-06	0.000201	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ALOX5—hematologic cancer	5.58e-06	0.000199	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PIK3CB—hematologic cancer	5.56e-06	0.000199	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MTOR—hematologic cancer	5.56e-06	0.000199	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GSTM1—hematologic cancer	5.53e-06	0.000198	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—NCOR1—hematologic cancer	5.53e-06	0.000198	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—UGT1A1—hematologic cancer	5.41e-06	0.000193	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	5.41e-06	0.000193	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NUP98—hematologic cancer	5.4e-06	0.000193	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ARNTL—hematologic cancer	5.39e-06	0.000193	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—MTAP—hematologic cancer	5.34e-06	0.000191	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—HRAS—hematologic cancer	5.31e-06	0.00019	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CRABP1—hematologic cancer	5.27e-06	0.000188	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—SLC22A1—hematologic cancer	5.27e-06	0.000188	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CA9—hematologic cancer	5.25e-06	0.000188	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ACP5—hematologic cancer	5.25e-06	0.000188	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ADCY7—hematologic cancer	5.25e-06	0.000188	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NCOA3—hematologic cancer	5.25e-06	0.000188	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CD44—hematologic cancer	5.22e-06	0.000187	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—NQO1—hematologic cancer	5.22e-06	0.000187	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CDKN1B—hematologic cancer	5.21e-06	0.000186	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NUP214—hematologic cancer	5.21e-06	0.000186	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NCOR2—hematologic cancer	5.18e-06	0.000185	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—AKT1—hematologic cancer	5.16e-06	0.000184	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.16e-06	0.000184	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ALOX5—hematologic cancer	5.13e-06	0.000183	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CASP3—hematologic cancer	5.11e-06	0.000183	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ABCG2—hematologic cancer	5.1e-06	0.000182	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—MTR—hematologic cancer	5.1e-06	0.000182	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—IL2—hematologic cancer	5.1e-06	0.000182	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—IL6—hematologic cancer	5.08e-06	0.000181	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ENO2—hematologic cancer	5e-06	0.000179	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CCND1—hematologic cancer	4.97e-06	0.000178	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NUP98—hematologic cancer	4.97e-06	0.000178	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—JUN—hematologic cancer	4.96e-06	0.000177	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CYCS—hematologic cancer	4.94e-06	0.000176	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—IDH1—hematologic cancer	4.93e-06	0.000176	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	4.91e-06	0.000175	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—MTHFR—hematologic cancer	4.89e-06	0.000175	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—TXN—hematologic cancer	4.88e-06	0.000174	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ABCC3—hematologic cancer	4.88e-06	0.000174	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTO1—hematologic cancer	4.88e-06	0.000174	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTT1—hematologic cancer	4.85e-06	0.000173	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ADCY7—hematologic cancer	4.83e-06	0.000172	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NCOA3—hematologic cancer	4.83e-06	0.000172	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CDKN1A—hematologic cancer	4.81e-06	0.000172	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PTEN—hematologic cancer	4.8e-06	0.000172	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NUP214—hematologic cancer	4.79e-06	0.000171	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.78e-06	0.000171	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—SPHK1—hematologic cancer	4.77e-06	0.000171	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—FHL2—hematologic cancer	4.76e-06	0.00017	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—SDC1—hematologic cancer	4.74e-06	0.00017	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MAPK8—hematologic cancer	4.7e-06	0.000168	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—MTR—hematologic cancer	4.69e-06	0.000168	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ABCG2—hematologic cancer	4.69e-06	0.000168	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—AKT1—hematologic cancer	4.68e-06	0.000167	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—AGRN—hematologic cancer	4.67e-06	0.000167	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ENO2—hematologic cancer	4.6e-06	0.000165	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—UGT1A1—hematologic cancer	4.59e-06	0.000164	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—EP300—hematologic cancer	4.58e-06	0.000164	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.53e-06	0.000162	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.47e-06	0.00016	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTT1—hematologic cancer	4.46e-06	0.00016	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—SLC22A1—hematologic cancer	4.46e-06	0.000159	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CRABP1—hematologic cancer	4.46e-06	0.000159	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—SRC—hematologic cancer	4.45e-06	0.000159	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—HMMR—hematologic cancer	4.43e-06	0.000158	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—IDH2—hematologic cancer	4.43e-06	0.000158	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—SDC1—hematologic cancer	4.36e-06	0.000156	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTP1—hematologic cancer	4.35e-06	0.000156	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ALOX5—hematologic cancer	4.35e-06	0.000155	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—VEGFA—hematologic cancer	4.34e-06	0.000155	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—STAT3—hematologic cancer	4.29e-06	0.000153	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—NRAS—hematologic cancer	4.28e-06	0.000153	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.28e-06	0.000153	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NUP98—hematologic cancer	4.21e-06	0.00015	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.16e-06	0.000149	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ABCB1—hematologic cancer	4.12e-06	0.000147	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PIK3CG—hematologic cancer	4.11e-06	0.000147	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MAPK3—hematologic cancer	4.1e-06	0.000147	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ADCY7—hematologic cancer	4.09e-06	0.000146	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NCOA3—hematologic cancer	4.09e-06	0.000146	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NUP214—hematologic cancer	4.06e-06	0.000145	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CA9—hematologic cancer	4.05e-06	0.000145	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ACP5—hematologic cancer	4.05e-06	0.000145	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NQO1—hematologic cancer	4.03e-06	0.000144	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CD44—hematologic cancer	4.03e-06	0.000144	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.02e-06	0.000144	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTM1—hematologic cancer	4e-06	0.000143	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—NCOR1—hematologic cancer	4e-06	0.000143	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NCOR2—hematologic cancer	4e-06	0.000143	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MYC—hematologic cancer	3.99e-06	0.000143	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—TGFB1—hematologic cancer	3.98e-06	0.000142	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—MTR—hematologic cancer	3.98e-06	0.000142	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ABCG2—hematologic cancer	3.98e-06	0.000142	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.95e-06	0.000141	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ENO2—hematologic cancer	3.9e-06	0.000139	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYCS—hematologic cancer	3.82e-06	0.000136	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CREBBP—hematologic cancer	3.81e-06	0.000136	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—IDH1—hematologic cancer	3.81e-06	0.000136	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	3.79e-06	0.000136	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTT1—hematologic cancer	3.78e-06	0.000135	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—TXN—hematologic cancer	3.76e-06	0.000135	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.76e-06	0.000135	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.76e-06	0.000135	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.72e-06	0.000133	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CD44—hematologic cancer	3.71e-06	0.000133	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NQO1—hematologic cancer	3.71e-06	0.000133	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—SDC1—hematologic cancer	3.7e-06	0.000132	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—KRAS—hematologic cancer	3.69e-06	0.000132	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.68e-06	0.000132	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PIK3CD—hematologic cancer	3.61e-06	0.000129	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ALB—hematologic cancer	3.57e-06	0.000127	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.54e-06	0.000127	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—MTHFR—hematologic cancer	3.53e-06	0.000126	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.53e-06	0.000126	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYCS—hematologic cancer	3.51e-06	0.000125	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	3.49e-06	0.000125	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.49e-06	0.000125	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.44e-06	0.000123	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.44e-06	0.000123	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.41e-06	0.000122	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PIK3R1—hematologic cancer	3.41e-06	0.000122	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PIK3CA—hematologic cancer	3.39e-06	0.000121	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTP1—hematologic cancer	3.36e-06	0.00012	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.36e-06	0.00012	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.33e-06	0.000119	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—TP53—hematologic cancer	3.28e-06	0.000117	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.26e-06	0.000116	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NUP98—hematologic cancer	3.25e-06	0.000116	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ABCB1—hematologic cancer	3.18e-06	0.000114	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.15e-06	0.000113	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.15e-06	0.000113	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PIK3CB—hematologic cancer	3.15e-06	0.000113	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NQO1—hematologic cancer	3.14e-06	0.000112	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CD44—hematologic cancer	3.14e-06	0.000112	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—HRAS—hematologic cancer	3.13e-06	0.000112	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NUP214—hematologic cancer	3.13e-06	0.000112	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTP1—hematologic cancer	3.09e-06	0.000111	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NCOR1—hematologic cancer	3.09e-06	0.000111	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTM1—hematologic cancer	3.09e-06	0.000111	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.08e-06	0.00011	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.07e-06	0.00011	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—MTR—hematologic cancer	3.07e-06	0.00011	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ENO2—hematologic cancer	3.01e-06	0.000108	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—IL6—hematologic cancer	3e-06	0.000107	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYCS—hematologic cancer	2.97e-06	0.000106	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PIK3CG—hematologic cancer	2.97e-06	0.000106	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	2.96e-06	0.000106	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ABCB1—hematologic cancer	2.93e-06	0.000105	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.92e-06	0.000104	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SDC1—hematologic cancer	2.85e-06	0.000102	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.84e-06	0.000102	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.84e-06	0.000102	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—AKT1—hematologic cancer	2.77e-06	9.89e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CREBBP—hematologic cancer	2.75e-06	9.84e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.73e-06	9.77e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PTEN—hematologic cancer	2.72e-06	9.72e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.66e-06	9.51e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.62e-06	9.37e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PIK3CD—hematologic cancer	2.61e-06	9.33e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—EP300—hematologic cancer	2.59e-06	9.27e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ALB—hematologic cancer	2.58e-06	9.21e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.54e-06	9.07e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.51e-06	8.98e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.48e-06	8.87e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PIK3R1—hematologic cancer	2.47e-06	8.81e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CD44—hematologic cancer	2.43e-06	8.67e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NQO1—hematologic cancer	2.43e-06	8.67e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.41e-06	8.61e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.41e-06	8.61e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.41e-06	8.61e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.3e-06	8.21e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYCS—hematologic cancer	2.3e-06	8.2e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.28e-06	8.15e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PIK3CB—hematologic cancer	2.28e-06	8.13e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.13e-06	7.61e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CREBBP—hematologic cancer	2.13e-06	7.61e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.11e-06	7.55e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.02e-06	7.23e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PIK3CD—hematologic cancer	2.02e-06	7.21e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ALB—hematologic cancer	1.99e-06	7.12e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PTEN—hematologic cancer	1.97e-06	7.03e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.96e-06	7e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PIK3CA—hematologic cancer	1.92e-06	6.86e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.92e-06	6.85e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.91e-06	6.81e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.88e-06	6.71e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—EP300—hematologic cancer	1.88e-06	6.7e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.86e-06	6.65e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.86e-06	6.65e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.86e-06	6.63e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ALB—hematologic cancer	1.83e-06	6.55e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.79e-06	6.39e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.76e-06	6.29e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.75e-06	6.27e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.66e-06	5.93e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.64e-06	5.87e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.62e-06	5.78e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.57e-06	5.62e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—AKT1—hematologic cancer	1.57e-06	5.6e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ALB—hematologic cancer	1.55e-06	5.55e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PTEN—hematologic cancer	1.52e-06	5.43e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.48e-06	5.31e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—EP300—hematologic cancer	1.45e-06	5.18e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PTEN—hematologic cancer	1.4e-06	5e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.39e-06	4.96e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.38e-06	4.93e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.37e-06	4.9e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—EP300—hematologic cancer	1.33e-06	4.77e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.28e-06	4.58e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.21e-06	4.34e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ALB—hematologic cancer	1.2e-06	4.28e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PTEN—hematologic cancer	1.18e-06	4.23e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.15e-06	4.1e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—AKT1—hematologic cancer	1.13e-06	4.05e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—EP300—hematologic cancer	1.13e-06	4.04e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.07e-06	3.83e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.06e-06	3.78e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PIK3CA—hematologic cancer	9.86e-07	3.53e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PTEN—hematologic cancer	9.14e-07	3.27e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—AKT1—hematologic cancer	8.76e-07	3.13e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—EP300—hematologic cancer	8.72e-07	3.12e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PIK3CA—hematologic cancer	8.36e-07	2.99e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—AKT1—hematologic cancer	8.06e-07	2.88e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—AKT1—hematologic cancer	6.83e-07	2.44e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PIK3CA—hematologic cancer	6.45e-07	2.3e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—AKT1—hematologic cancer	5.27e-07	1.88e-05	CbGpPWpGaD
